1552 - Transcatheter Aortic Valve Implantation (TAVI) via Transfemoral Delivery for Patients at Intermediate Risk for Surgery

Page last updated: 18 March 2019

Application Detail



Description of Medical Service

The TAVI procedure is a transfemoral percutaneous minimally invasive insertion of a prosthetic heart valve that is positioned within the native aortic annulus. Once in situ, the valve is expanded while the heart is rapidly paced. The procedure is performed under fluoroscopic and transosophageal guidance and under general anaesthesia or local anaesthetic.

Description of Medical Condition

Severe Aortic Stenosis (AS) is a narrowing of the aortic valve restricting the flow. Aortic stenosis is often caused by a build-up of calcium on the valve leaflets, causing them to become stiff and reducing their ability to open and close efficiently. AS is associated with high pressure inside the left ventricle and as a result of the excessive workload, the muscle of the left ventricle hypertrophies. This results in inefficient pumping of blood throughout the body. Left untreated, congestive heart failure develops and death is likely.

Reason for Application

TAVI is listed on the Medical Benefits Schedule (MBS) (Item 38495), This application requests an amendment to the patient population to include patients at intermediate risk of surgery.

Medical Service Type


Previous Application Number

1361, 1361.1, 1361.2

Associated Documentation

Application Form

Application Form (Word 132 KB)
Application Form (PDF 867 KB)

Consultation Survey

Consultation Survey (Word 508 KB)
Consultation Survey (PDF 305 KB)

PICO Confirmation

PICO Confirmation (PDF 1056 KB)
PICO Confirmation (Word 227 KB)

Assessment Report


Public Summary Document


Meetings for this Application


6-7 December 2018